The Biozipcode Group is a project team led by Biozipcode, Inc. (Japan), composed of multiple affiliated companies and institutions involved in medical research, pharmaceutical development, business implementation, international collaboration, and token operations. Research and development are carried out in partnership with academic institutions in Japan, while manufacturing and implementation are handled by partner companies in ...

Utility Token A blockchain-based token that grants access to specific services—such as paying platform fees, unlocking premium features, or settling medical-tour payments—without conferring dividends or voting rights. Its value is driven mainly by actual demand and limited supply; regulatory frameworks usually treat it as non-security when properly structured. Security Token A digital asset representing an ...

Biozipcode™ is a peptide-based drug delivery technology that attaches a “cell-specific postal code” to drugs or diagnostic probes, enabling them to reach only the intended target cells. From combinations of 20 amino acids, seven-digit sequences are designed—yielding over 1.3 billion theoretical combinations—and a code is selected that can be uniquely recognized by the target cell. ...

A Diabetic Stem Cell refers to a research term describing hematopoietic stem cells in the bone marrow that become epigenetically abnormal when exposed to high blood glucose levels. Under normal conditions, hematopoietic stem cells produce blood cells and support tissue repair throughout the body. However, in hyperglycemic environments, the expression of histone deacetylases (HDACs) becomes ...